HC Wainwright Boosts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $10.00
Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its price target hoisted by HC Wainwright from $9.00 to $10.00 in a report published on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Separately, JMP Securities reaffirmed a market outperform rating and issued a $9.00 price objective on shares of Aquestive Therapeutics […]
3 Oct 06:40 · The Markets Daily